When should prophylaxis therapy in inhibitor patients be considered?
about
Treatment and Prevention of Bleeds in Haemophilia Patients with Inhibitors to Factor VIII/IXThe economics of inpatient on-demand treatment for haemophilia with high-responding inhibitors: a US retrospective data analysis.Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in ItalyChallenges and successes in the treatment of hemophilia: the story of a patient with severe hemophilia A and high-titer inhibitors.Key issues in inhibitor management in patients with haemophilia.Factor VIII inhibitors in hemophilia A: rationale and latest evidence
P2860
When should prophylaxis therapy in inhibitor patients be considered?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
When should prophylaxis therapy in inhibitor patients be considered?
@en
When should prophylaxis therapy in inhibitor patients be considered?
@nl
type
label
When should prophylaxis therapy in inhibitor patients be considered?
@en
When should prophylaxis therapy in inhibitor patients be considered?
@nl
prefLabel
When should prophylaxis therapy in inhibitor patients be considered?
@en
When should prophylaxis therapy in inhibitor patients be considered?
@nl
P2093
P2860
P1433
P1476
When should prophylaxis therapy in inhibitor patients be considered?
@en
P2093
B A Konkle
E Santagostino
G Auerswald
V Blanchette
V Jimenez-Yuste
P2860
P304
P356
10.1111/J.1365-2516.2011.02494.X
P50
P577
2011-03-21T00:00:00Z